$AMBS Q1 filed. Reg A updated filing in progress to help consummate the Cutanogen sale + debt extinguishment. MANF endothelial cell patent filing was a major development re COVID and Long COVID. Elto Pharma + MANF is the future for AMBS development programs
https://twitter.com/G_Commish/status/15278085...g&s=19